Pneumothorax Treatment Market Size, Share, Trends, Growth 2034

Pneumothorax Treatment Market

Pneumothorax Treatment Market By Type (Primary Spontaneous, Secondary Spontaneous, Injury Related, Iatrogenic, and Catamenial), By Treatment (Antibiotics, Medication, Opiate Anesthetics, Benzodiazepines, and Others), By Diagnosis (Ultrasound, Chest X-ray, Physical Examination, and Computerized Tomography Scan), By End-User (Clinics, Hospitals, and Ambulatory Distribution Channel), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2026 - 2034

Category: Healthcare Report Format : PDF Pages: 229 Report Code: ZMR-10853 Published Date: Nov-2026 Status : Published
Market Size in 2025 Market Forecast in 2034 CAGR (in %) Base Year
USD 32.99 Billion USD 52.57 Billion 5.31% 2025

Pneumothorax Treatment Industry Perspective:

What is the anticipated size of the pneumothorax treatment market during the projection period?

The global pneumothorax treatment market size was worth around USD 32.99 billion in 2025 and is predicted to grow to around USD 52.57 billion by 2034, with a compound annual growth rate (CAGR) of roughly 5.31% between 2026 and 2034.

Global Pneumothorax Treatment Market SizeRequest Free Sample


Key Insights:

  • As per the analysis shared by our research analyst, the global pneumothorax treatment market is estimated to grow annually at a CAGR of around 5.31% over the forecast period (2026-2034)
  • In terms of revenue, the global pneumothorax treatment market size was valued at around USD 32.99 billion in 2025 and is projected to reach USD 52.57 billion, by 2034.
  • The pneumothorax treatment market is projected to grow at a significant rate due to the grow due to rising prevalence of the condition, expansion of healthcare infrastructure, and medical innovations.
  • Based on the type, the secondary spontaneous segment is growing at a high rate and will continue to dominate the global market as per industry projection.
  • Based on the treatment, the opiate anesthetics segment is anticipated to command the largest market share.
  • Based on the diagnosis, the computerized tomography scan segment is expected to lead the market growth trends.
  • Based on the end-user, the hospitals segment is projected to influence revenue in the market.
  • Based on region, North America is projected to dominate the global market during the forecast period.

Pneumothorax Treatment Market: Overview

Pneumothorax treatment involves using different medical procedures and instruments to relieve pressure on the lungs. Pneumothorax is caused by lung collapse, leading to an air leak between the chest wall and the patient’s lung. It can be spontaneous or caused by traumatic injuries. Pneumothorax can develop due to medical procedures such as mechanical ventilation and lung biopsies. Pneumothorax treatments include needle aspiration, nonsurgical repair, chest tube insertion, or observation, depending on severity. During the forecast period, demand for pneumothorax treatment is expected to grow due to rising prevalence of the condition, expansion of healthcare infrastructure, and medical innovations. However, the market may remain limited because of insufficient diagnostic facilities, patient preference for conservative treatments, and concerns about treatment-related side effects.

Impact of the USA-Israel and Iran war on the Pneumothorax Treatment Market:

The USA-Israel and Iran war has impacted the supply chain and cost of medical devices in the last few months. Delayed delivery of medical equipment and pharmaceutical products, as well as a surge in logistics expenses, are some of the leading negative impacts of the ongoing geopolitical conflict. However, demand for pneumothorax treatment is expected to continue growing in the coming years as war-related medical emergencies increase traumatic pneumothorax incidence.

Pneumothorax Treatment Market: Dynamics

Growth Drivers

How will the rising prevalence of the condition be expected to aid growth in the pneumothorax treatment market?

The global pneumothorax treatment market is expected to benefit from the rising cases of punctured lungs worldwide. It is caused when air enters the space between the lung and the chest. This can build pressure on the lung, resulting in complete or partial collapse. According to the Cleveland Clinic, pneumothorax can be of two types: spontaneous and traumatic. Other types include catamenial and tension pneumothorax. Medical conditions such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, lung cancer, and other medical conditions can also cause pneumothorax. A growing number of traumatic injuries due to road accidents, falls, occupation hazard, and sports-related injuries, including accidents caused in conflict regions, may drive market revenue in the long run.

Expansion of healthcare infrastructure to support market growth during the forecast period

Healthcare infrastructure is rapidly expanding worldwide. Growing world population, a rising geriatric population, and a surge in medical interventions are propelling demand for more effective healthcare and diagnostic systems. In June 2026, the European Investment Bank (EIB) announced a EUR 500 million agreement to modernize and expand healthcare facilities in the region. In July 2026, Mexico introduced a MX$ 181 billion-worth hospital infrastructure plan. Such initiatives are expected to encourage more revenue in the pneumothorax treatment market.

Restraints

High cost of treatment and limited infrastructure restrict pneumothorax treatment industry growth

The global pneumothorax treatment industry is anticipated to be restricted due to the high cost of treatment, especially surgical interventions. In addition, invasive pneumothorax treatment such as chest-tube drainage poses the risk of patient discomfort, allergic reaction, and bleeding. Medical professionals may choose non-invasive or non-surgical procedures depending on case severity. A shortage of skilled medical professionals may further limit growth for industry players.

Opportunities

What are the ongoing advancements in the pneumothorax treatment market that are expected to create growth opportunities?

The global pneumothorax treatment market is gaining a significant amount of investment for continuous research & development (R&D). This includes work on better understanding the role of observation instead of intervention, as well as the introduction and development of advanced chest drainage systems, improved pleurodesis approaches, and portable air-leak monitoring devices. New research by scientists at the Center for Clinical Research in Emergency Medicine (CCREM) at Royal Perth Hospital shows that observation has proven to significantly improve patient outcomes, instead of intervention. The study included participation by 316 patients across Australia. Out of them, around 162 patients were given pain relief medication and managed solely with observation. About 85% of these patients had outcomes similar to those of patients who received standard treatment.

Challenges

What are the leading challenges affecting growth in the pneumothorax treatment industry?

The global pneumothorax treatment industry is projected to be restricted due to growing consumer preference for conservative treatments. Patients with minimal symptoms do not prefer advanced treatments. In addition, lack of standard healthcare infrastructure in emerging parts of the world and limited research on novel therapies may impact industry revenue in the long run.

Pneumothorax Treatment Market: Report Scope

Report Attributes Report Details
Report Name Pneumothorax Treatment Market
Market Size in 2025 USD 32.99 Billion
Market Forecast in 2034 USD 52.57 Billion
Growth Rate CAGR of 5.31%
Number of Pages 229
Key Companies Covered Becton Dickinson and Company (BD), Medtronic, ATMOS MedizinTechnik, Cook Medical, Sinapi Biomedical, Teleflex Incorporated, Vygon, Merit Medical Systems, Cardinal Health, Utah Medical Products, Nobelpharma, Medela, Argon Medical Devices, Rocket Medical, Getinge, and others.
Segments Covered By Type, By Treatment, By Diagnosis, By End-User, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2025
Historical Year 2020 - 2024
Forecast Year 2026 - 2034
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Pneumothorax Treatment Market: Segmentation

The global pneumothorax treatment market is segmented based on type, treatment, diagnosis, end-user, and region.

Why will the injury-related segment lead the pneumothorax treatment industry revenue during the forecast period?

Based on type, the global market is fragmented into primary spontaneous, secondary spontaneous, injury-related, iatrogenic, and catamenial. In 2025, the secondary spontaneous segment showed the highest growth. It accounted for the majority of the global revenue. During the forecast period, the injury-related segment is expected to generate the highest CAGR. Growing number of occupational incidents, escalating war situations, and geopolitical conflicts will drive segmental growth in the coming years.

Which will be the fastest-growing treatment during the forecast period in the pneumothorax treatment market?

Based on treatment, the global market fragments are antibiotics, medication, opiate anesthetics, benzodiazepines, and others. In 2025, the opiate anesthetics segment led the market growth rate. During the forecast period, it is expected to generate the fastest growth due to the growing use of opiate anesthetics as multimodal pain management solutions during surgical interventions.

Which factors drive demand in the computerized tomography scan segment in the pneumothorax treatment industry?

Based on diagnosis, the global market is segmented into ultrasound, chest X-ray, physical examination, and computerized tomography scan. In 2025, the computerized tomography scan segment was the highest revenue generator and will continue leading the market with significant revenue. Computerized tomography scans can detect occult pneumothoraxes and are widely used for detecting underlying lung diseases.

What will be the influence of the hospitals segment on the pneumothorax treatment market?

Based on end-user, the global market segments are clinics, hospitals, and ambulatory distribution channels. In 2025, the hospitals segment was the leading revenue generator with the largest share. During the forecast period, it will continue generating the highest CAGR. Rapid expansion of healthcare infrastructure, favorable government initiatives, rising disposable income, and a surge in national welfare programs will promote segmental revenue.

Pneumothorax Treatment Market: Regional Analysis

Why will North America lead the pneumothorax treatment market in the coming years?

The global pneumothorax treatment market is currently led by North America. In 2025, it accounted for the largest share of the global revenue and will contribute up to 35.5% of the market share by the end of the projection period. It will grow at a strong CAGR of 5.9% during the forecast period. Growing healthcare expenditure, a vast network of hospitals & diagnostic centers, and increasing research will support regional growth.

Why will Asia-Pacific generate the fastest CAGR in the pneumothorax treatment market during the forecast period?

Asia-Pacific is expected to emerge as the fastest-growing region in the pneumothorax treatment market with a CAGR of 8.41% during the forecast period and control over 21.9% of the global revenue. Rising pneumothorax prevalence, growing patient awareness, expanding healthcare facilities and medical reimbursement policies, and improved diagnostic infrastructure will support growth in Asia-Pacific. Moreover, growing medical tourism across India and China will further facilitate growth in the region.

Pneumothorax Treatment Market: Competitive Analysis

The global pneumothorax treatment market is led by players like:

  • Becton Dickinson and Company (BD)
  • Medtronic
  • ATMOS MedizinTechnik
  • Cook Medical
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Vygon
  • Merit Medical Systems
  • Cardinal Health
  • Utah Medical Products
  • Nobelpharma
  • Medela
  • Argon Medical Devices
  • Rocket Medical
  • Getinge

What are the latest key trends in the pneumothorax treatment market?

Rising popularity of ambulatory pneumothorax management

The launch of digital and portable drainage systems is aiding the growing popularity of ambulatory pneumothorax management. Clinical guidelines from the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS) recommend ambulatory services in areas with supportive infrastructure.

Artificial Intelligence (AI) integrations

The growing use of AI for diagnostic purposes is emerging as a prominent market trend. AI-enabled chest X-rays enable faster, more accurate diagnosis, reducing the risk of clinical errors.

The global pneumothorax treatment market is segmented as follows:

By Type

  • Primary Spontaneous
  • Secondary Spontaneous
  • Injury Related
  • Iatrogenic
  • Catamenial

By Treatment

  • Antibiotics
  • Medication
  • Opiate Anesthetics
  • Benzodiazepines
  • Others

By Diagnosis

  • Ultrasound
  • Chest X-ray
  • Physical Examination
  • Computerized Tomography Scan

By End-User

  • Clinics
  • Hospitals
  • Ambulatory Distribution Channel

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Table Of Content

Methodology

FrequentlyAsked Questions

Pneumothorax treatment is the use of different medical procedures and instruments to relieve pressure on the lungs.

The global pneumothorax treatment market is expected to benefit from the rising cases of punctured lungs worldwide.

According to study, the global pneumothorax treatment market size was worth around USD 32.99 billion in 2025 and is predicted to grow to around USD 52.57 billion by 2034.

The CAGR value of the pneumothorax treatment market is expected to be around 5.31% during 2026-2034.

The global pneumothorax treatment industry is projected to be restricted due to growing consumer preference for conservative treatments.

Rising popularity of ambulatory pneumothorax management and Artificial Intelligence (AI) integrations are the emerging trends and innovations impacting the pneumothorax treatment market.

The global pneumothorax treatment market has performed well so far and will offer similar trends in the coming years.

North America will contribute notably towards the pneumothorax treatment market value.

The global pneumothorax treatment market is led by players like Becton Dickinson and Company (BD), Medtronic, ATMOS MedizinTechnik, Cook Medical, Sinapi Biomedical, Teleflex Incorporated, Vygon, Merit Medical Systems, Cardinal Health, Utah Medical Products, Nobelpharma, Medela, Argon Medical Devices, Rocket Medical, and Getinge.

The report explores crucial aspects of the pneumothorax treatment market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.

HappyClients